Kwong Connie H. 4

4 · MAXLINEAR, INC · Filed Feb 23, 2026

AI-generated summary of this filing

Updated Feb 23, 2026

MaxLinear (MXL) Controller Connie Kwong Receives 25,152-Share Award

What Happened

Connie H. Kwong, Corporate Controller & Principal Accounting Officer of MaxLinear (MXL), received performance-based equity awards totaling 25,152 shares in February 2026. The filing shows 9,231 shares and 1,702 shares issued on Feb 20, 2026 (reported at $0.00 per share as awards) and 14,219 restricted stock units (RSUs) reported on Feb 18, 2026 (derivative award). The filing does not list a cash purchase price — awards are listed at $0.00 per share and their value is determined using the company’s closing stock price (per footnote).

Key Details

Transactions reported:
- 2026-02-20: 9,231 shares issued (Award) — $0.00 per share (Footnote F1)
- 2026-02-20: 1,702 shares issued (Award) — $0.00 per share (Footnote F2)
- 2026-02-18: 14,219 RSUs granted (Derivative) — $0.00 per unit (Footnotes F3, F4)
Total shares/units: 25,152
Shares owned after transaction: not specified in the filing.
Plans and conditions:
- Awards issued under the Amended and Restated 2010 Equity Incentive Plan and the Executive Incentive Bonus Plan (F1, F2).
- RSUs = contingent right to one share each; vesting schedule: 1/3 on May 20, 2027, then annually so fully vested May 20, 2029, subject to continued service (F3, F4).
Filing timeliness: Form 4 filed 2026-02-23 reporting transactions on Feb 18 and Feb 20. Required reporting is normally within two business days, so the filing was submitted after those dates (check for potential late reporting).

Context

These were awards/grants (not open-market purchases or sales). Awards reported at $0.00 are standard for equity grants; the economic value depends on MaxLinear’s market price (footnote indicates award amounts were determined using the Feb 20, 2026 closing price).
RSUs are contingent — they do not represent immediately transferable shares until they vest.
For retail investors: award grants are routine compensation for executives and do not by themselves signal buying or selling intent; purchases are generally more informative about personal conviction.

Form 4

Period: 2026-02-18

Corporate Controller & PAO

Transactions

Award
Common Stock
[F1]
2026-02-20+9,231→ 67,383 total
Award
Common Stock
[F2]
2026-02-20+1,702→ 69,085 total
Award
Restricted Stock Units
[F3][F4]
2026-02-18+14,219→ 14,219 total
→ Common Stock (14,219 underlying)

Footnotes (4)

[F1]Represents shares of Common Stock issued to the Reporting Person for the 2025 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's Amended and Restated 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 20, 2026.
[F2]Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2025 fiscal year that were approved as part of the 2025 performance-based restricted stock award granted on August 4, 2025. All shares were issued pursuant to the Company's Amended and Restated 2010 Equity Incentive Plan.
[F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
[F4]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Company's Amended and Restated 2010 Equity Incentive Plan) through each applicable vesting date, one-third (1/3rd) of the RSUs subject to the award will vest on May 20, 2027, and one-third (1/3rd) of the RSUs subject to the award will vest annually on each May 20 thereafter, such that the award will be fully vested on May 20, 2029.

Signature

/s/ Connie Kwong|2026-02-23

1 file